Northwestern Mutual Wealth Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
Other funds holding CASI
VA
WP
Northwestern Mutual Wealth Management's CASI Position: Q4 2025 in Review
Northwestern Mutual Wealth Management sold out of CASI Pharmaceuticals (CASI) in Q4 2025, closing a stake of 13 shares — an estimated $22 sold.
Northwestern Mutual Wealth Management first reported a position in CASI in Q4 2019 and held it in 24 quarters. The position peaked at $93 in Q4 2023. 16 funds tracked by Wall St. Rank hold CASI as of Q4 2025.
- Northwestern Mutual Wealth Management reported no remaining CASI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 13 CASI Pharmaceuticals shares in Q4 2025, an estimated $22.
- Northwestern Mutual Wealth Management first reported a position in CASI Pharmaceuticals in Q4 2019 and held it in 24 quarters.
- Northwestern Mutual Wealth Management's CASI Pharmaceuticals position peaked at $93 in Q4 2023.
- 16 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.